000			03550cam a2200493 a 4500
001			u307231
003			SIRSI
005			20160811205822.0
008			080228s2007 sz ab gr 000 0 eng
020			_a9789241563482
020			_a9241563486
040			_cMX-MeUAM
050		0	_aRD96.2 _bW37 2007
100	1		_aWarrell, D. A.
245	1	0	_aRabies and envenomings : _ba neglected public health issue : report of a consultative meeting, World Health Organization, Geneva, 10 January 2007 / _c[prepared by D. Warrell and J-M Gutiérrez].
260			_aGeneva : _bWorld Health Organization, _cc2007.
300			_a32 p. : _bil., col., maps ; _c24 cm.
500			_a"This Report was developed by compiling the information provided at the WHO Consultative Meeting on Rabies and Envenomings: a Neglected Public Health Issue that took place at WHO, Geneva on 10 January 2007"--T.p. verso.
504			_aIncluye referencias bibliográficas (p. 29-30).
505	2		_aIntroduction -- Rabies and envenomings : neglected diseases -- Epidemiology : the burden of disease -- Production and control of therapeutic antisera -- Distribution and appropriate use of therapeutic antisera : failure to supply those at greatest need -- Scales of production : the need to strengthen capacity -- Prequalification of antisera : the way to improve access to quality and safe products -- Towards a global solution : a WHO intiative to improve availability of safe antisera.
520			_aThe aim of this consultative meeting was to discuss strategies for improving the quality and quantity of therapeutic antisera, essential drugs for the effective treatment of suspected rabid dog bites and envenoming by snake bites and scorpion stings. Inadequacies in the efficacy, safety and production of these antisera have created a major global public health crisis, especially in Africa and Asia. Each year, millions of people are bitten by dogs or snakes or stung by scorpions and the failure to provide antisera costs at least 150,000 lives and at least as many cases of permanent physical handicap. The solution to this crisis demands an international effort to promote transfer of technology to affected countries, to improve standards through the WHO's prequalification scheme and to facilitate distribution of antisera and training of medical personnel in their optimal use.--Publisher's description.
650		7	_aRabia _xPacientes _xCuidades médicos. _2lemb
650		7	_aRabia _xEpidemiología. _2lemb
650		7	_aRabia _xQuimioterapia. _2lemb
650		7	_aMordeduras y picaduras _xPacientes _xCuidados médicos. _2lemb
650		7	_aMordeduras y picaduras _xEpidemiología. _2lemb
650		7	_aMordeduras y picaduras _xQuimioterapia. _2lemb
650		7	_aSueros inmunes _xUso terapeútico. _2lemb
650		7	_aAnimales venenosos _xVenenos animales _xEfectos fisiológicos. _2lemb
650		0	_aRabies _xPatients _xMedical care.
650		0	_aRabies _xEpidemiology.
650		0	_aRabies _xChemotherapy.
650		0	_aBites and stings _xPatients _xMedical care.
650		0	_aBites and stings _xEpidemiology.
650		0	_aBites and stings _xChemotherapy.
650		0	_aImmune serums _xTherapeutic use.
650		0	_aPoisonous animals _xVenom _xPhysiological effect.
700	1		_aGutiérrez, J-M _q(José María), _eprepared
710	2		_aWorld Health Organization.
856	4	1	_uhttp://www.who.int/bloodproducts/animal_sera/Rabies.pdf _zConnect to online resource
596			_a4 12
942			_cLIBRO
999			_c150126 _d150126